查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1557332

血糖試紙市場－2024年至2029年預測

Blood Glucose Test Strips Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

血糖試紙市場預計將從2024年的135.67億美元成長到2029年的178.28億美元，成長率為5.61%（複合年成長率）

血糖試紙是用來檢查血液中血糖濃度的塑膠試紙。當血液樣本放置在試紙條的一端時，它會與一種稱為葡萄糖氧化酵素的化學物質發生反應，產生葡萄糖酸。然後測量演算法分析這種酸以確定血糖值。

推動此類醫療器材市場擴大的主要因素是糖尿病患者數量的增加，其次是血糖監測技術的提高和自我健康意識的提高。此外，市場參與者積極投資新試紙的推出，進一步引領市場的上升軌跡。

然而，在製造試紙時使用塑膠引起了人們對此類工具的環境擔憂，從而阻礙了整體市場的成長。同樣，食品藥物管理局（FDA）等主要權威機構對試紙生產和使用的嚴格規定也提高了產品的技術水準。

血糖檢測試紙市場促進因素：

  • 糖尿病盛行率的增加預計將推動整體市場的擴張。

糖尿病是全球主要死亡原因之一，I型和II型糖尿病的發生率在主要國家顯著增加。全球糖尿病盛行率的不斷上升被認為是血糖試紙市場成長的關鍵驅動力，因為糖尿病治療需要持續監測血糖值。

據國際糖尿病聯盟稱，到 2030 年，將有近 6.43 億人患有糖尿病。 2045年，這一數字將達到7.83億人，其中2型糖尿病是主要類型。而且，根據同一資訊來源，在歐洲等主要地區，95%的糖尿病患者患有II型糖尿病，到2030年，糖尿病患者總數將達到6700萬，而2021年為6100萬。

世界衛生組織 (WHO) 等主要衛生組織表示，大多數糖尿病病例發生在低收入和中等收入國家。因此，這些國家需要負擔得起的檢測方案來監測血糖濃度。血糖試紙在低收入和中等收入國家有很大的市場，因為與基於感測器的監測儀相比，它們是一種負擔得起的選擇。

  • 政府加強糖尿病監測的有利舉措預計將推動市場成長。

與其他選擇相比，血糖試紙易於使用、高度準確且價格實惠。與需要醫療干預的基於感測器的糖尿病測試設備不同，血糖試紙設備可以由個人使用。

由於生活方式的改變以及患有糖尿病的成人和兒童人數的增加，各國政府和主要醫療機構正在推出加強常規糖尿病篩檢的策略和計劃。例如，2022年11月，歐洲議會通過了歐盟範圍內的糖尿病策略，以支持糖尿病的診斷、研究和治療。

同樣，根據 PIB 2023 年 8 月的公告，印度政府與衛生和家庭福利部合作，宣布根據「國家衛生使命」向各邦和中央直轄區提供技術和財政支持。此舉旨在加強對包括糖尿病在內的常見非傳染性疾病的預防和篩檢。

  • 人們對糖尿病的認知不斷提高正在推動市場擴張。

血糖值試紙比其他選擇具有優勢，例如更容易使用、更準確且更實惠。糖尿病檢測是所有年齡層最常見的預防措施之一。隨著 COVID-19 的出現，預防措施進一步加強，因為它對糖尿病和嚴重氣喘患者有生命危險。因此，檢測次數增多，血糖試紙的使用量也隨之增加。

此外，成年人口的快速成長等其他因素也刺激了市場擴張，因為成年人口佔全球糖尿病人口的主要佔有率。例如，根據 2023 年 11 月《糖尿病研究與臨床實務》發表的一項研究顯示，華人成人糖尿病患者佔全球的主要比例。

血糖試紙市場的地域展望

  • 亞太地區佔主要市場佔有率

全球血糖試紙市場分為北美、南美、歐洲、中東和非洲，預計亞太地區將佔據重要的市場佔有率。

根據國際糖尿病聯盟預測，2030年，亞太地區的糖尿病人口將佔全球的54%，2045年將佔到52%。同樣，根據印度醫學研究委員會發布的「印度糖尿病」研究報告，該國糖尿病患者人數已達1.01億人。此外，根據澳洲糖尿病協會的數據，截至2023年9月，約有150萬澳洲人患有糖尿病，其中II型糖尿病佔總數的86.7%。據同一資訊來源稱，過去 12 個月新登記病例數為 113,907 例。

限制血糖試紙市場的因素：

  • 對條帶中使用塑膠的環境擔憂可能會限制市場成長。

血糖試紙由塑膠製成，有環境問題。糖尿病患者的比例為1：11，而這些試紙是一次性使用的，所以它們總是可以幫助人們監測他們的糖尿病。隨著不斷的創新和技術改進，新技術和更好的技術始終面臨威脅。血糖試紙是較經濟的選擇之一。

血糖試紙主要市場開拓

  • 2024年3月，諾瓦生物醫學推出新一代「StatStrip」血糖醫院計量系統。該產品提高了血糖檢查的準確性，並採用 LINUX-OS 中的下一代計量系統。

血糖試紙市場細分與分析如下：

依糖尿病類型

  • 一型糖尿病
  • II型糖尿病

按分銷管道

  • 線上
  • 離線

按最終用戶

  • 醫院和診所
  • 門診手術中心
  • 診斷中心

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他
  • 中東 中東/非洲
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 其他
  • 亞太地區
  • 中國
  • 澳洲
  • 日本
  • 韓國
  • 印度
  • 泰國
  • 台灣
  • 印尼
  • 其他

目錄

第1章 簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章血糖試紙市場：依糖尿病類型

  • 介紹
  • 1型糖尿病
  • 2型糖尿病

第6章血糖試紙市場：依通路

  • 介紹
  • 線上
  • 離線

第7章血糖試紙市場：依最終用戶分類

  • 介紹
  • 醫院和診所
  • 門診手術中心
  • 診斷中心

第8章血糖試紙市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 澳洲
    • 日本
    • 韓國
    • 印度
    • 泰國
    • 台灣
    • 印尼
    • 其他

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Abbott Diabetes Care
  • F. Hoffmann-La Roche Ltd
  • AgaMatrix, Inc.
  • Bayer
  • LifeScan IP Holdings, LLC
  • Care Touch USA
  • GenUltimate!
  • Arkray Inc
  • Metene
  • Medtronic
簡介目錄
Product Code: KSI061611895

The blood glucose test strips market is expected to grow to US$17.828 billion in 2029 from US$13.567 billion in 2024 at a 5.61% (CAGR)

Blood glucose test strips are plastic strips used to check the level of glucose in the blood. At one end of the strip, a sample of blood is put in, and it reacts with a chemical called glucose oxidase, producing gluconic acid. The metering algorithm then analyzes this acid to identify the blood glucose level.

The major factor driving the market expansion for such medical tools is the growing number of diabetic patients, followed by favorable efforts to bolster glucose monitoring technologies and the growing awareness regarding self-health. Moreover, market players' favorable investments in new testing strip launches have further led to an upward market trajectory.

However, the use of plastic for making test strips has raised certain environmental concerns about such tools, thereby hampering the overall market growth. Likewise, the stringent regulations laid by major authorities such as the Food and Drug Administration regarding test strip production and usage have also increased the level of technicalities for the product.

Blood Glucose Test Strips Market Drivers:

  • The growing prevalence of diabetes is expected to augment the overall market expansion.

Diabetes is becoming one of the major causes of death globally, with major economies witnessing a significant growth in their frequency of diabetic patients, both Type I and Type II. Such increasing prevalence of diabetes worldwide is considered the key driver for the blood glucose test strips market growth, as diabetes treatment requires consistent monitoring of blood glucose levels.

According to the International Federation of Diabetes, by 2030, nearly 643 million people will have diabetes. By 2045, this figure will reach 783 million, with the major type being type 2 diabetes. Moreover, the same source stated that in major regions such as Europe, 95% of the diabetic cases are of Type II diabetes, and by 2030, the total number of diabetic patients will reach 67 million, thereby showcasing a 9% growth over 2021's frequency of 61 million.

Major health organizations, namely the World Health Organization, suggest that the majority of diabetes cases occur in low to middle-income countries. Therefore, to monitor glucose levels in these countries, affordable testing options are needed. Blood glucose test strips, as compared to sensor-based monitors, are an affordable option and thus have a huge market in low and middle-income countries.

  • Favorable government initiatives to bolster diabetes monitoring are expected to drive market growth.

Blood glucose testing strips are easy to use, highly accurate, and affordable compared to other options available. Unlike sensor-based diabetes testing devices, which require medical intervention, blood glucose test strip devices can be used by individuals themselves.

Because of lifestyle changes and an increasing number of cases of diabetes in adults and children, the governments of countries and major health organizations are initiating strategies and schemes to bolster constant diabetes check-ups. For instance, in November 2022, the European Parliament adopted an EU-wide diabetes strategy to support diabetes diagnosis, research & treatment.

Likewise, according to the PIB August 2023 release, the Indian government, in collaboration with the Department of Health and Family Welfare, announced technical and financial support to states and union territories under the "National Health Mission." This aimed to bolster the prevention and screening of common non-communicable diseases, including diabetes, in the country.

  • Increasing awareness regarding diabetes has stimulated the market expansion.

Blood glucose testing strips have exceptional qualities, like being easy to use, high accuracy, and affordability compared to other options available. Diabetes testing is one of the most common preventative measures among people of all ages. With the start of COVID-19, the precautions have further increased, as it is life-threatening to diabetic and severe asthmatic patients. Thus, this caused an increase in the number of tests and a further increase in the usage of blood glucose testing strips.

Moreover, other factors, such as the booming adult population, have also stimulated market expansion since the adult population accounts for a major share of the global diabetic volume. For instance, according to a research study published in November 2023 in Diabetes Research and Clinical Practice, China accounts for a major share of adults having diabetes globally.

Blood Glucose Test Strips Market Geographical Outlook

  • Asia Pacific is set to account for a significant market share

The global blood glucose test strips market regionally is analyzed into North America, South America, Europe, Middle East and Africa, and Asia Pacific, where the APAC region is set to constitute a considerable market share as fuelled by the growing prevalence of diabetes in major regional economies namely China and India.

According to the International Federation of Diabetes, by 2030, the Asia Pacific region will account for 54% of the global diabetic population and 52% by 2045. Likewise, according to the "Indian Diabetes" research study published by the Indian Council of Medical Research, the prevalence of diabetes in the country reached 101 million. Moreover, as per Diabetes Australia, as of September 2023, nearly 1.5 million Australians have diabetes, and Type II accounted for a maximum portion of 86.7% of all cases. Hence, the same source specified that the frequency of newly registered cases reached 113,907 over the last twelve months.

Blood Glucose Test Strips Market Restraints:

  • Environmental concerns regarding plastic usage in strips can restrain the market growth.

Blood glucose test strips are made of plastic, which has environmental issues. With a ratio of 1 to 11 for diabetes, these test strips constantly help to monitor people's diabetes since they are one-time use and have their fair share of environmental concerns. With constant innovation and technological improvement, there is always a threat to new and better technology. Blood glucose test strips are one of the more economical options.

Blood Glucose Test Strips Key Market Developments

  • In March 2024, Nova Biomedical launched its new generation "StatStrip" glucose hospital meter system, which uses FDA-certified strips for blood glucose monitoring of critically ill patients. The product improves glucose-checking accuracy and features a LINUX-OS next-generation meter system.

The Blood Glucose Test Strips market is segmented and analyzed as given below:

By Diabetes Type

  • Type I Diabetes
  • Type II Diabetes

By Distribution Channel

  • Online
  • Offline

By End-User

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostics Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Australia
  • Japan
  • South Korea
  • India
  • Thailand
  • Taiwan
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. BLOOD GLUCOSE TEST STRIPS MARKET BY DIABETES TYPE

  • 5.1. Introduction
  • 5.2. Type I Diabetes
  • 5.3. Type II Diabetes

6. BLOOD GLUCOSE TEST STRIPS MARKET BY DISTRIBUTION CHANNEL

  • 6.1. Introduction
  • 6.2. Online
  • 6.3. Offline

7. BLOOD GLUCOSE TEST STRIPS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Surgery Centers
  • 7.4. Diagnostic Centers

8. BLOOD GLUCOSE TEST STRIPS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. UK
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. Australia
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. India
    • 8.6.6. Thailand
    • 8.6.7. Taiwan
    • 8.6.8. Indonesia
    • 8.6.9. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott Diabetes Care
  • 10.2. F. Hoffmann-La Roche Ltd
  • 10.3. AgaMatrix, Inc.
  • 10.4. Bayer
  • 10.5. LifeScan IP Holdings, LLC
  • 10.6. Care Touch USA
  • 10.7. GenUltimate!
  • 10.8. Arkray Inc
  • 10.9. Metene
  • 10.10. Medtronic